Filing Details
- Accession Number:
- 0001562180-25-001025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-07 16:38:11
- Reporting Period:
- 2025-02-05
- Filing Date:
- 2025-02-07
- Accepted Time:
- 2025-02-07 16:38:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1710072 | Edgewise Therapeutics Inc. | EWTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1185829 | Kevin Koch | C/O Edgewise Therapeutics, Inc. 1715 38Th Street Boulder CO 80301 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-05 | 8,636 | $0.18 | 23,114 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-05 | 8,636 | $30.03 | 14,478 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-02-06 | 900 | $13.11 | 15,378 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-06 | 900 | $31.13 | 14,478 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-05 | 8,636 | $0.00 | 8,636 | $0.18 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-06 | 900 | $0.00 | 900 | $0.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 42,545 | 2021-06-13 | 2027-08-08 | No | 4 | M | Direct |
| 41,645 | 2021-06-13 | 2027-08-08 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 259,554 | Indirect | KTK Family Enterprise, LLC |
| Common Stock | 26,410 | Indirect | Nicole M. Soldow Heritage Trust |
| Common Stock | 26,410 | Indirect | Adrienne R. Koch Heritage Trust |
| Common Stock | 26,410 | Indirect | Matthew K. Koch Heritage Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024.
- The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.14, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.03 to $30.1311, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- These shares are held directly by the KTK Family Enterprise, LLC for the which the Reporting Person serves as Manager.
- These shares are held directly by the Nicole M. Soldow Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.
- These shares are held directly by the Adrienne R. Koch Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.
- These shares are held directly by the Matthew K. Koch Heritage Trust for which the Reporting Person and his spouse serve as co-trustees.
Billionaire Hedge Funds
